Clinical decision support
The company will use the funds to advance its AI-enabled robotic platform for cataract and other eye surgeries, with plans to begin human clinical trials this year.
The Series E funding comes four months after the company secured $250 million in a Series D round.
Selected early versions will be slated for real-world deployment.
Funding from the venture capital firm's Customer Value Fund will allow Commure to accelerate its expansion in healthcare without ownership dilution.
The funding comes on the heels of the fax automation company's $37 million Series B funding round and $18 million Series A raise last year.
Anne Osdoit, CEO of Moon Surgical, discusses the company’s Maestro surgical robotics system and how it supports surgeons during soft tissue procedures.
Lyrebird Health plans to scale its operation internationally, beginning in the United Kingdom.
NUS Medicine’s latest model has outperformed DNA-based biological ageing clocks and demonstrated a stronger capability to predict mortality.
What they offer is not a passive but an active clinical assistant that thinks beyond consultation notes.
Also, radiology reporting solutions provider Kailo Medical has acquired a clinician-founded genAI company.